GLP-1 RAs were associated with a significant reduction in all-cause mortality and CV mortality, and did not increase the risk of sudden cardiac death, atrial arrythmias, or ventricular arrhythmias in T2DM patients (75, 76). This evidence concerns the gene GLP1R and Ventricular arrhythmia.